Previous 10 | Next 10 |
Gainers: T2 Biosystems ( TTOO ) +73% . Veru ( VERU ) +38% . Ginkgo Bioworks ( DNA ) +21% . Inotiv ( NOTV ) +20% . Accuray ( ARAY ) +17% . Losers: Athenex ( ATNX ) -46% . Invitae ( NVTA ) -43% . Cer...
Image source: The Motley Fool. Accuray (NASDAQ: ARAY) Q4 2022 Earnings Call Aug 10, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Accuray (ARAY) Q4 2022 Earnings Call Transcript
Accuray Inc. ( NASDAQ: ARAY ) is up 5% in after-hours trading after reporting fiscal 2022 Q4 results that beat on the top and bottom lines and issuing a FY 2023 revenue estimate that falls within analyst consensus. The company projects FY 2023 revenue of $447M-$455...
Accuray press release ( NASDAQ: ARAY ): Q4 GAAP EPS of -$0.04 beats by $0.03 . Revenue of $110.02M (-0.8% Y/Y) beats by $4.7M . Shares +2.3% . Gross orders of $88.3 million The Company is introducing guidance for fiscal year 2023 as follows: ...
Accuray Reports Fourth Quarter and Fiscal 2022 Financial Results PR Newswire 8.5% FY22 revenue growth; Company issues guidance for FY23 SUNNYVALE, Calif. , Aug. 10, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial ...
Accuray to Report Fiscal Year-End 2022 Financial Results on August 10, 2022 PR Newswire SUNNYVALE, Calif. , July 27, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter and fiscal year 2022, e...
Accuray CyberKnife® System Real World Data and Clinical Studies Show Benefits in Treatment of Neurological Indications PR Newswire SUNNYVALE, Calif. , July 12, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new cli...
Accuray (NASDAQ:ARAY), a developer of radiation therapy systems is trading higher for the fourth consecutive session on Thursday after B. Riley Securities launched its coverage with a Buy recommendation citing among other things a YTD decline in company’s value. “Although ARAY s...
Accuray (ARAY) stock gained as much as 9.6% to $2.11 in Thursday trading, after B Riley research initiated coverage on the radiation therapy company with a buy rating. B Riley analyst Neil Chatterji gave ARAY stock a price target of $7.50, which is nearly four times that of ARAY's l...
Accuray Appoints Franco N. Palomba as VP, Chief Accounting Officer & Controller Accuray Appoints Franco N. Palomba as VP, Chief Accounting Officer & Controller PR Newswire SUNNYVALE, Calif. , June 15, 2022 /PRNewswire/ -- Accuray Incorporated ...
News, Short Squeeze, Breakout and More Instantly...
Accuray Incorporated Company Name:
ARAY Stock Symbol:
NASDAQ Market:
A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) rose 30.3% to $0.2932 on volume of 173,918,707 shares Emergent Biosolutions Inc. (EBS) rose 71.0% to $3.3 on volume of 150,987,238 shares PROSHARES TRUST (SQQQ) fell 3.6% to $11.78 on volume of 136,332,744 sh...
A look at the top 10 most actives in the United States Allarity Therapeutics Inc. (ALLR) rose 97.8% to $2.71 on volume of 44,141,232 shares Faraday Future Intelligent Electric Inc. (FFIE) fell 1.1% to $0.0456 on volume of 28,670,184 shares Emergent Biosolutions Inc. (EBS) rose 67.7% to $3...
Accuray Reports Fiscal 2024 Third Quarter Financial Results PR Newswire MADISON, Wis. , May 1, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter and nine-months ended March 31, 2024 . ...